Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcanna Inc. stock logo
CLIQ
Alcanna
C$0.00
C$5.89
C$10.20
C$327.85MN/A253,253 shs555,803 shs
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
$85.98
-1.6%
$94.89
$68.09
$127.50
$7.60B1.721.79 million shs1.39 million shs
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
$68.49
$68.47
$21.65
$73.02
$4.62B0.452.07 million shs74 shs
JOANN Inc. stock logo
JOAN
JOANN
$0.25
$0.08
$2.19
$4.06M0.991.23 million shs4.43 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcanna Inc. stock logo
CLIQ
Alcanna
0.00%0.00%0.00%0.00%0.00%
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
0.00%-0.06%-3.57%-4.30%+5.55%
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
0.00%0.00%0.00%0.00%0.00%
JOANN Inc. stock logo
JOAN
JOANN
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcanna Inc. stock logo
CLIQ
Alcanna
C$0.00
C$5.89
C$10.20
C$327.85MN/A253,253 shs555,803 shs
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
$85.98
-1.6%
$94.89
$68.09
$127.50
$7.60B1.721.79 million shs1.39 million shs
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
$68.49
$68.47
$21.65
$73.02
$4.62B0.452.07 million shs74 shs
JOANN Inc. stock logo
JOAN
JOANN
$0.25
$0.08
$2.19
$4.06M0.991.23 million shs4.43 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcanna Inc. stock logo
CLIQ
Alcanna
0.00%0.00%0.00%0.00%0.00%
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
0.00%-0.06%-3.57%-4.30%+5.55%
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
0.00%0.00%0.00%0.00%0.00%
JOANN Inc. stock logo
JOAN
JOANN
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alcanna Inc. stock logo
CLIQ
Alcanna
0.00
N/AN/AN/A
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
2.86
Moderate Buy$115.2134.00% Upside
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
0.00
N/AN/AN/A
JOANN Inc. stock logo
JOAN
JOANN
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest JOAN, H24, GBT, FOUR, and CLIQ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/6/2025
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$100.00 ➝ $92.00
8/6/2025
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$125.00 ➝ $115.00
8/6/2025
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$104.00
8/6/2025
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$113.00 ➝ $107.00
8/6/2025
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetMarket Perform$110.00 ➝ $100.00
8/5/2025
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/1/2025
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingStrong-Buy$130.00 ➝ $140.00
7/17/2025
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$97.00 ➝ $109.00
7/17/2025
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$120.00
7/9/2025
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetMarket Perform$95.00 ➝ $110.00
(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alcanna Inc. stock logo
CLIQ
Alcanna
C$726.27M0.00N/A7.66C$4.49 per share0.00
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
$3.33B2.28$6.75 per share12.73$11.43 per share7.52
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
$194.75M23.73N/AN/A$3.05 per share22.46
JOANN Inc. stock logo
JOAN
JOANN
$2.16B0.00N/A0.09($1.20) per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alcanna Inc. stock logo
CLIQ
Alcanna
N/AC$1.028.87N/AN/AN/AN/AN/AN/A
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
$229.60M$2.7031.8418.250.866.11%37.05%6.88%11/11/2025 (Estimated)
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
-$303.09M-$5.01N/AN/AN/A-137.30%-170.37%-39.24%N/A
JOANN Inc. stock logo
JOAN
JOANN
-$200.60M-$5.81N/AN/AN/A-11.10%N/A-4.99%N/A

Latest JOAN, H24, GBT, FOUR, and CLIQ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
$1.20$1.10-$0.10$0.32$967.84 million$413.40 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alcanna Inc. stock logo
CLIQ
Alcanna
N/A7.14%N/AN/AN/A
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
N/AN/AN/AN/AN/A
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
N/AN/AN/AN/AN/A
JOANN Inc. stock logo
JOAN
JOANN
$0.44N/AN/AN/A 1 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alcanna Inc. stock logo
CLIQ
Alcanna
121.51
3.35
1.03
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
2.99
2.53
2.53
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
4.92
6.88
6.17
JOANN Inc. stock logo
JOAN
JOANN
N/A
1.43
0.20

Institutional Ownership

CompanyInstitutional Ownership
Alcanna Inc. stock logo
CLIQ
Alcanna
N/A
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
98.87%
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
N/A
JOANN Inc. stock logo
JOAN
JOANN
72.10%

Insider Ownership

CompanyInsider Ownership
Alcanna Inc. stock logo
CLIQ
Alcanna
N/A
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
25.15%
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
4.90%
JOANN Inc. stock logo
JOAN
JOANN
73.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alcanna Inc. stock logo
CLIQ
Alcanna
2,26436.23 millionN/ANot Optionable
Shift4 Payments, Inc. stock logo
FOUR
Shift4 Payments
4,00088.43 million66.19 millionOptionable
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
45767.48 million64.17 millionOptionable
JOANN Inc. stock logo
JOAN
JOANN
20,00041.91 million11.15 millionOptionable

Recent News About These Companies

Spirit Halloween and Paranormal Cirque coming to Hagerstown in September
Two killed in multi-vehicle crash on SR 115 in Allen County
Ariola, NYPD team up for backpack giveaway

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alcanna stock logo

Alcanna TSE:CLIQ

Alcanna Inc. engages in the retailing of alcohol in North America. The company retails wines, beers, and spirits; and cannabis products It operates 176 locations in Alberta and British Columbia; and 53 cannabis retail stores in Alberta, Ontario, and Saskatchewan. The company was formerly known as Liquor Stores N.A. Ltd. and changed its name to Alcanna Inc. in May 2018. Alcanna Inc. was founded in 2004 and is headquartered in Edmonton, Canada. As of March 30, 2022, Alcanna Inc. operates as a subsidiary of Sundial Growers Inc.

Shift4 Payments stock logo

Shift4 Payments NYSE:FOUR

$85.98 -1.42 (-1.62%)
Closing price 03:59 PM Eastern
Extended Trading
$86.80 +0.81 (+0.95%)
As of 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Shift4 Payments, Inc. (NYSE FOUR) provides integrated payment processing and technology solutions in the United States. Its payments platform provides omni-channel card acceptance and processing solutions, including end-to-end payment processing for various payment types; merchant acquiring; proprietary omni-channel gateway; complementary software integrations; integrated and mobile point-of-sale (POS) solutions; security and risk management solutions; and reporting and analytical tools, as well as tokenization, risk management/underwriting, payment device and chargeback management, fraud prevention, and gift card solutions. The company also offers suite of technology solutions, such as Lighthouse, a cloud-based business intelligence tool that includes customer engagement, social media management, online reputation management, scheduling, and product pricing, as well as reporting and analytics; integrated POS for merchants business; and Skytab, a mobile payment solution. In addition, it provides marketplace technology that enable seamless integrations into third-party applications, which includes online delivery services, payroll, timekeeping, and other human resource services. Further, the company offers merchant management, training and education, marketing management, and incentives tracking solutions. Additionally, it provides merchant underwriting, onboarding and activation, training, risk management, and support services; and software integrations and compliance management, and partner support and services. The company was founded in 1998 and is headquartered in Allentown, Pennsylvania.

Global Blood Therapeutics stock logo

Global Blood Therapeutics NASDAQ:GBT

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.

JOANN stock logo

JOANN NASDAQ:JOAN

JOANN Inc. operates as a specialty retailer of sewing and fabrics, and arts and crafts category products in the United States. The company products in sewing category include cotton fabrics; warm fabrics, such as fleece and flannel fabrics; home decorating and utility fabrics and accessories; fashion and sportswear fabrics; special occasion fabrics; pillow forms; stuffing, batting, and foams; seasonally themed and licensed fabric designs; and sewing construction supplies comprising cutting implements, threads, zippers, trims, tapes, pins, elastic, and buttons, as well as patterns for sewing projects. Its products in arts and crafts, home décor, and other categories consist of yarn and yarn accessories, and needlecraft kits and supplies; paper crafting components; craft materials; fine art materials; sewing machines, craft technology, lighting, irons, organizers, and other products; artificial floral products; seasonal décor and entertaining products; home décor accessories; ready-made frames; comprehensive assortment books and magazines; and non-merchandise services. The company offers its products through retail stores, as well as online. The company was formerly known as Jo-Ann Stores Holdings Inc. and changed its name to JOANN Inc. in February 2021. JOANN Inc. was founded in 1943 and is based in Hudson, Ohio. On March 18, 2024, JOANN Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.